290 related articles for article (PubMed ID: 32209757)
1. New insights into Wnt signaling alterations in amyotrophic lateral sclerosis: a potential therapeutic target?
Gonzalez-Fernandez C; González P; Rodríguez FJ
Neural Regen Res; 2020 Sep; 15(9):1580-1589. PubMed ID: 32209757
[TBL] [Abstract][Full Text] [Related]
2. Wnt Signaling Alteration in the Spinal Cord of Amyotrophic Lateral Sclerosis Transgenic Mice: Special Focus on Frizzled-5 Cellular Expression Pattern.
González-Fernández C; Mancuso R; Del Valle J; Navarro X; Rodríguez FJ
PLoS One; 2016; 11(5):e0155867. PubMed ID: 27192435
[TBL] [Abstract][Full Text] [Related]
3. Opposite Interplay between PPAR Gamma and Canonical Wnt/Beta-Catenin Pathway in Amyotrophic Lateral Sclerosis.
Lecarpentier Y; Vallée A
Front Neurol; 2016; 7():100. PubMed ID: 27445967
[TBL] [Abstract][Full Text] [Related]
4. Wnt Signaling Alterations in the Human Spinal Cord of Amyotrophic Lateral Sclerosis Cases: Spotlight on Fz2 and Wnt5a.
González-Fernández C; Gonzalez P; Andres-Benito P; Ferrer I; Rodríguez FJ
Mol Neurobiol; 2019 Oct; 56(10):6777-6791. PubMed ID: 30924074
[TBL] [Abstract][Full Text] [Related]
5. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
[TBL] [Abstract][Full Text] [Related]
6. Rapidly progressive amyotrophic lateral sclerosis is associated with microglial reactivity and small heat shock protein expression in reactive astrocytes.
Gorter RP; Stephenson J; Nutma E; Anink J; de Jonge JC; Baron W; Jahreiβ MC; Belien JAM; van Noort JM; Mijnsbergen C; Aronica E; Amor S
Neuropathol Appl Neurobiol; 2019 Aug; 45(5):459-475. PubMed ID: 30346063
[TBL] [Abstract][Full Text] [Related]
7. Activation of the Wnt/β-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice.
Chen Y; Guan Y; Liu H; Wu X; Yu L; Wang S; Zhao C; Du H; Wang X
Biochem Biophys Res Commun; 2012 Apr; 420(2):397-403. PubMed ID: 22426476
[TBL] [Abstract][Full Text] [Related]
8. Strategies for clinical approach to neurodegeneration in Amyotrophic lateral sclerosis.
Carlesi C; Pasquali L; Piazza S; Lo Gerfo A; Caldarazzo Ienco E; Alessi R; Fornai F; Siciliano G
Arch Ital Biol; 2011 Mar; 149(1):151-67. PubMed ID: 21412722
[TBL] [Abstract][Full Text] [Related]
9. Current view and perspectives in amyotrophic lateral sclerosis.
Mathis S; Couratier P; Julian A; Corcia P; Le Masson G
Neural Regen Res; 2017 Feb; 12(2):181-184. PubMed ID: 28400790
[TBL] [Abstract][Full Text] [Related]
10. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
Bruneteau G; Simonet T; Bauché S; Mandjee N; Malfatti E; Girard E; Tanguy ML; Behin A; Khiami F; Sariali E; Hell-Remy C; Salachas F; Pradat PF; Fournier E; Lacomblez L; Koenig J; Romero NB; Fontaine B; Meininger V; Schaeffer L; Hantaï D
Brain; 2013 Aug; 136(Pt 8):2359-68. PubMed ID: 23824486
[TBL] [Abstract][Full Text] [Related]
11. Antagonizing bone morphogenetic protein 4 attenuates disease progression in a rat model of amyotrophic lateral sclerosis.
Shijo T; Warita H; Suzuki N; Ikeda K; Mitsuzawa S; Akiyama T; Ono H; Nishiyama A; Izumi R; Kitajima Y; Aoki M
Exp Neurol; 2018 Sep; 307():164-179. PubMed ID: 29932880
[TBL] [Abstract][Full Text] [Related]
12. The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis.
Ngo ST; Steyn FJ
Cell Regen; 2015; 4(1):5. PubMed ID: 26322226
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review).
Martin LJ; Price AC; Kaiser A; Shaikh AY; Liu Z
Int J Mol Med; 2000 Jan; 5(1):3-13. PubMed ID: 10601567
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
15. The potential roles of aquaporin 4 in amyotrophic lateral sclerosis.
Zou S; Lan YL; Wang H; Zhang B; Sun YG
Neurol Sci; 2019 Aug; 40(8):1541-1549. PubMed ID: 30980198
[TBL] [Abstract][Full Text] [Related]
16. Amyotrophic Lateral Sclerosis Model.
Azuma Y; Mizuta I; Tokuda T; Mizuno T
Adv Exp Med Biol; 2018; 1076():79-95. PubMed ID: 29951816
[TBL] [Abstract][Full Text] [Related]
17. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
[TBL] [Abstract][Full Text] [Related]
18. DREAM-Dependent Activation of Astrocytes in Amyotrophic Lateral Sclerosis.
Larrodé P; Calvo AC; Moreno-Martínez L; de la Torre M; Moreno-García L; Molina N; Castiella T; Iñiguez C; Pascual LF; Mena FJM; Zaragoza P; Y Cajal SR; Osta R
Mol Neurobiol; 2018 Jan; 55(1):1-12. PubMed ID: 28840473
[TBL] [Abstract][Full Text] [Related]
19. Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice.
Chen Y; Guan Y; Zhang Z; Liu H; Wang S; Yu L; Wu X; Wang X
Neurol Res; 2012 May; 34(4):390-9. PubMed ID: 22643084
[TBL] [Abstract][Full Text] [Related]
20. Lower and upper motor neuron involvement and their impact on disease prognosis in amyotrophic lateral sclerosis.
Zakharova MN; Abramova AA
Neural Regen Res; 2022 Jan; 17(1):65-73. PubMed ID: 34100429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
